NYSE - Delayed Quote USD

Stryker Corporation (SYK)

382.64
+0.29
+(0.08%)
At close: May 30 at 4:00:02 PM EDT
379.81
-2.83
(-0.74%)
After hours: May 30 at 4:37:41 PM EDT

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Kevin A. Lobo Chairman, CEO & President 5.28M 43.3M 1965
Mr. Viju S. Menon Group President of Global Quality & Operations 1.57M -- 1968
Mr. Glenn S. Boehnlein CPA Advisor 2.11M 19.83M 1962
Mr. J. Andrew Pierce Group President of MedSurg & Neurotechnology 1.88M 2.37M 1974
Mr. Spencer S. Stiles Group President of Orthopaedics & Spine 1.88M -- 1977
Mr. Preston Wells VP & CFO -- -- --
Mr. William E. Berry Jr. VP & Chief Accounting Officer -- -- 1966
Mr. Robert C. Cohen CTO and VP of Global R&D - Joint Replacement -- -- --
Mr. Alan Douville VP, Chief Information Officer & Chief Information Security Officer -- -- --
Mr. Jason Beach Vice President of Finance & Investor Relations -- -- --

Stryker Corporation

1941 Stryker Way
Portage, MI 49002
United States
(269) 385-2600 https://www.stryker.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
53,000

Description

Stryker Corporation operates as a medical technology company. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke, cranial, and maxillofacial and chest wall devices, as well as dural substitutes and sealants; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries; thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Corporate Governance

Stryker Corporation’s ISS Governance QualityScore as of June 1, 2025 is 5. The pillar scores are Audit: 8; Board: 6; Shareholder Rights: 6; Compensation: 1.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

June 30, 2025 at 12:00 AM UTC

Ex-Dividend Date

July 29, 2025 at 8:00 PM UTC

Stryker Corporation Earnings Date

July 31, 2025 at 12:00 AM UTC

Dividend Date

Recent Events

May 30, 2025 at 12:00 AM UTC

S-8: Offering Registrations

May 23, 2025 at 12:00 AM UTC

SD: Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)

May 13, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 2, 2025 at 12:00 AM UTC

10-Q: Periodic Financial Reports

May 1, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

March 25, 2025 at 12:00 AM UTC

DEFA14A: Proxy Statements

February 27, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

February 19, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

February 12, 2025 at 12:00 AM UTC

IRANNOTICE: Notice of disclosure filed in Exchange Act quarterly and annual reports pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Exchange Act

February 10, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers